The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
8.47
+0.02 (0.24%)
Dec 5, 2025, 4:00 PM EST - Market closed
The Joint Market Cap
The Joint has a market cap or net worth of $125.92 million as of December 5, 2025. Its market cap has decreased by -23.27% in one year.
Market Cap
125.92M
Enterprise Value
98.31M
1-Year Change
-23.27%
Ranking
Category
Stock Price
$8.47
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $125.92M, an increase of 108.82%. That is a compound annual growth rate of 6.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 125.90M | -20.97% |
| Dec 31, 2024 | 159.30M | 12.34% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |